( 2 ) Similar safety profiles were observed in the two treatment groups , with 21.1 % adverse event ( AE ) ( 8.3 % study-drug related AE ) in the fluvastatin XL group and 17.0 % AE ( 6.3 % study-drug related AE ) in the fluvastatin IR group .